Ethos Technologies Inc. (LIFE) Earnings Call Transcripts

7 earnings calls from February 2025 to August 3, 2026

NasdaqGS US Financials Insurance

Ethos Technologies Inc.'s Latest Earnings Call - Q1 FY2026

In Q1 2026, Lifecare ASA reported revenue of NOK 7.08 million, primarily from government grants, marking a significant operational transition as the company moves towards a more scalable manufacturing model. The quarter was characterized by key milestones, including achieving CE mark for implant electronics and demonstrating stable implant performance beyond 12 weeks. Management has signaled a shift in strategy, simplifying the regulatory pathway and focusing on cost reductions, with expectations of a 35% decrease in employee expenses going forward. The company has also recognized a NOK 12 million impairment loss related to the wind-down of its German operations, which will not impact cash flow.

Reported metrics

MetricValueContext
Revenue NOK 7.08 million (miss) primarily from government grants, down from NOK 12 million in Q1 2025
Impairment Loss NOK 12 million (negative) related to the wind-down of German operations
Employee Benefit Expenses NOK 8.5 million (positive) in line with Q4 2025 and down from NOK 9.5 million in Q1 2025
Other Operating Expenses NOK 9.5 million (positive) down from NOK 12 million in Q4 2025
Cash Position NOK 26 million (positive) up from NOK 6 million at the start of the quarter
Cost Reduction Expectation 35% (positive) expected reduction in employee benefit expenses going forward

Guidance from management

Management expects to provide a more detailed roadmap regarding regulatory strategy and operational execution by the next quarterly report in August 2026. They anticipate significant cost reductions and improved operational efficiency as they transition to the Bergen facility.

What analysts pressed on

Analysts expressed concerns regarding the timeline for regulatory approvals and the impact of the German operations wind-down on future performance. There were questions about the company's ability to generate revenue from the veterinary market in the near term, with management indicating that significant revenues are not expected in H2 2026.

Main topics on the call

Read the full Ethos Technologies Inc. transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Ethos Technologies Inc.

Ethos Technologies Inc. (LIFE) is a publicly listed company in the Insurance industry, within the Financials sector. It trades on NasdaqGS and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 7 calls on record spanning February 20, 2025 to August 3, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 7 Ethos Technologies Inc. earnings call transcripts on record, spanning February 20, 2025 to August 3, 2026. Based on this history, Ethos Technologies Inc. reports quarterly. The most recent call on file is dated August 3, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
LIFE
Exchange
NasdaqGS
Country
US
Sector
Financials
Industry
Insurance
Calls on record
7
First call
February 20, 2025
Most recent
August 3, 2026
Reporting cadence
quarterly
Quarter Date
Q2 FY2026 Aug 3, 2026 Read transcript
Q1 FY2026 May 15, 2026 Read transcript
Q1 FY2026 May 6, 2026 Read transcript
Q4 FY2025 Mar 3, 2026 Read transcript
Q3 FY2026 Feb 25, 2026 Read transcript
Q1 FY2025 May 15, 2025 Read transcript
Q4 FY2024 Feb 20, 2025 Read transcript